Potentiation of excitotoxicity in HIV-1-associated Dementia and the significance of glutaminase
- 1 December 2006
- journal article
- Published by Elsevier in Clinical Neuroscience Research
- Vol. 6 (5) , 315-328
- https://doi.org/10.1016/j.cnr.2006.09.009
Abstract
No abstract availableKeywords
This publication has 195 references indexed in Scilit:
- The neuropathogenesis of AIDSNature Reviews Immunology, 2005
- Memantine Treatment in Patients With Moderate to Severe Alzheimer Disease Already Receiving DonepezilJAMA, 2004
- Physical and Genetic Linkage of Glutaminase (Gls), Signal Transducer and Activator of Transcription 1 (Stat1), and Xeroderma Pigmentosum Complementation Group G (Xpg) on Mouse Proximal Chromosome 1Genomics, 1998
- Deleterious Network: A Testable Pathogenetic Concept of Alzheimer’s DiseaseGerontology, 1997
- Ca2+ permeable AMPA/kainate channels permit rapid injurious Ca2+ entryNeuroReport, 1995
- Phosphate‐activated glutaminase expression during tumor developmentFEBS Letters, 1994
- Histochemistry of glutamate metabolizing enzymes in the rat cerebellar cortexNeuroscience Letters, 1991
- A glutaminase (Gls) gene maps to mouse chromosome 1, rat chromosome 9, and human chromosome 2*1Genomics, 1989
- Glutamine and Glucose as Precursors of Transmitter Amino Acids: Ex Vivo StudiesJournal of Neurochemistry, 1983
- REGIONAL CHANGES IN AMINO ACID CONTENT IN DEVELOPING RAT BRAIN1Journal of Neurochemistry, 1974